1
What is osteogenic loading?
OsteoStrong uses uniquely designed equipment to safely load your musculoskeletal system and trigger adaptive responses that stimulate growth of bone and muscle. This is called osteogenic loading - the principle that bones adapt and grow stronger when they receive forces above a specific threshold. Sessions are just 15 minutes, once per week, and are guided by a certified coach.
2
Bone density research: analysis from 152 peer-reviewed studies
A meta-analysis of 152 peer-reviewed studies compared the effect of different interventions on bone mineral density. OsteoStrong sessions showed approximately 14% improvement - significantly outperforming bone anabolic drugs (~7%), bisphosphonate drugs (~2.5%), weight-bearing exercise (~1%), whole body vibration, walking, and no activity. In all studies, participants also took calcium and vitamin D3 supplements.
3
Published trial: BMD improvements in postmenopausal women
A 24-week observational trial published in the Journal of Osteoporosis & Physical Activity (Hunte, Jaquish & Huck, 2015) studied 55 postmenopausal women with osteopenia or osteoporosis. Participants used osteogenic loading through lower extremity and spinal erection kinetic chains. Results showed statistically significant increases in functional loading and bone performance - a 131% and 126% increase in musculoskeletal functional kinetic chain activity. The DXA subgroup saw bone density increases of 14.9% in the hip and 16.6% in the spine (p<0.01 in both).
4
The four Spectrum machines
Each session uses four biomechanically designed Spectrum devices that target different areas of the body. The Core Growth Trigger targets the lower rib cage and deep abdominals. The Lower Growth Trigger targets the lower body. The Postural Growth Trigger targets the spine for bone and muscle density. The Upper Growth Trigger targets the upper body. Each device includes correct positioning protocols and safety procedures - you never push past your comfort zone, and you’re always in control of the force you apply.
5
Strength gain case study: 500 participants over 4 years
A longitudinal case study tracked 500 people (average age 52) performing 7-minute sessions once per week. Strength gains compounded over time: 73% increase after 1 year, 138% after 2 years, 201% after 3 years, and 290% after 4 years. These results demonstrate that consistency with osteogenic loading produces progressively greater improvements in functional strength.
6
Type 2 diabetes and blood glucose research
A pilot study published in the Journal of Diabetes & Metabolism (Hunte & Jaquish, 2015) examined osteogenic loading in 21 adults with pre-type 2 diabetes over 24 weeks. Results showed a statistically significant 8.8% reduction in HbA1c levels (from 6.37 to 5.81), with no significant changes in weight or BMI. Osteogenic loading outperformed caloric restrictive diet, weight-bearing exercise, metformin (without weight loss), and cardiovascular exercise in A1c reduction. Psychological wellbeing scores also improved by 8 points.
7
High-impact activity and bone density: the JBMR study
A population-based study of 724 adolescents published in the Journal of Bone and Mineral Research (Deere et al., 2012) found that only high-impact physical activity - impacts above 4.2g of force - was positively related to hip bone mineral density and bone geometry. Walking, jogging, and moderate exercise showed little to no benefit. This supports the core principle behind osteogenic loading: bones need forces well above everyday activity levels to trigger meaningful adaptation.
8
Endorsed by American Bone Health
John Jaquish, PhD, Board Member of American Bone Health (the largest bone health society in the world), wrote a letter to physicians explaining how osteogenic loading applies to patient care. The letter states that OsteoStrong’s therapy has no adverse effects, has been shown to be safe with 65,000+ users worldwide, and has several peer-reviewed publications and multiple presentations at the World Congress of Osteoporosis.
9
World Congress of Osteoporosis presentation
Research by Huck & Jaquish was presented at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015) and published in Osteoporosis International. The study analyzed functional bone performance in 2,380 adults using osteogenic loading apparatus for 12 or more sessions over one year. Results showed MOB force/loading levels correlated with DXA results, presenting a new metric of functional bone performance for ambulatory individuals with low BMD.
10
Safety profile and contraindications
Across all published studies and clinical use with 65,000+ users worldwide, osteogenic loading has shown no adverse effects. Because the user is always in control of the force they apply, and sessions are supervised by certified coaches, the therapy is safe for individuals with osteopenia and osteoporosis. Contraindications include patients who are not ambulatory, those in acute pain, unmedicated hypertensive individuals, individuals with muscular dystrophy, and hyperparathyroid patients whose condition is not yet controlled.
11
Why your doctor will appreciate this research
This research packet was compiled specifically so you can share it with your physician. It includes peer-reviewed journal articles, a physician letter from American Bone Health, and real member results verified through DEXA scans. Over 100 referring physicians in the Austin and Georgetown area trust OsteoStrong because the evidence is transparent, the results are measurable, and the approach complements standard medical care.
